---
title: "AstraZeneca's US Investment, Future of Psychedelic Therapy | Bloomberg Businessweek Daily 7/29/2025"
date: 2025-07-29T20:41:15+08:00
categories: ["finance"]
tags: ["LSE:AZN"]
summary: "On today's episode of Bloomberg Businessweek Daily with Tim Stenovec and Carol Massar, Pascal Soriot, Chief Executive Officer of AstraZeneca discusses the company's quarterly earnings. Kabir Nath, Chi"
source_url: "https://www.bloomberg.com/news/videos/2025-07-29/bloomberg-businessweek-daily-7-29-2025-video"
---

On today's episode of Bloomberg Businessweek Daily with Tim Stenovec and Carol Massar, Pascal Soriot, Chief Executive Officer of AstraZeneca discusses the company's quarterly earnings. Kabir Nath, Chief Executive Officer of Compass Pathways, on the pursuit of FDA approval of the first psychedelic treatment for certain people living with depression. Also, Bloomberg's Molly Smith and Oliver Crook on US-China Trade talks and the FOMC meeting (Source: Bloomberg)

---

*来源: [原文链接](https://www.bloomberg.com/news/videos/2025-07-29/bloomberg-businessweek-daily-7-29-2025-video)*
